Sylvain Terraz

University of Geneva

Papers

2

Total Citations

108

H-Index

2

About

Sylvain Terraz is a leading figure in interventional oncology, whose work bridges the gap between minimally invasive surgery and advanced image-guided therapies. His research primarily focuses on the treatment of hepatocellular carcinoma (HCC) and the development of novel high-intensity focused ultrasound (HIFU) techniques. Terraz’s most influential contribution is a landmark case–control study comparing minimally invasive surgery to percutaneous radio frequency ablation for single small HCCs (≤3 cm), which has garnered 86 citations and provides critical evidence for treatment selection in early-stage liver cancer. In a more recent and technically innovative work (22 citations), he pioneered a self-scanned HIFU ablation method that leverages real-time hybrid US-MR imaging to compensate for respiratory motion—a major hurdle in abdominal treatments. By keeping the focal spot static and using natural tissue motion to create the heating pattern, this approach represents a paradigm shift in non-invasive tumor ablation. Terraz’s work is notable for its clinical relevance and technical ingenuity, making him a key contributor to safer, more effective, and motion-adaptive cancer therapies.

Research Focus

Key Achievements

2
H-Index
2
Papers
108
Total Citations
54
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (≤3 cm) hepatocellular carcinoma: a case–control study
86 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Geneva

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago